185 related articles for article (PubMed ID: 6365657)
41. A glycoside-hydrolase inhibitor in treatment of dumping syndrome.
McLoughlin JC; Buchanan KD; Alam MJ
Lancet; 1979 Sep; 2(8143):603-5. PubMed ID: 90270
[TBL] [Abstract][Full Text] [Related]
42. Carbohydrate malabsorption following acarbose administration.
Sobajima H; Mori M; Niwa T; Muramatsu M; Sugimoto Y; Kato K; Naruse S; Kondo T; Hayakawa T
Diabet Med; 1998 May; 15(5):393-7. PubMed ID: 9609361
[TBL] [Abstract][Full Text] [Related]
43. Delay of carbohydrate absorption by inhibitors of intestinal alpha-glucosidases.
Puls W; Krause HP
Adv Exp Med Biol; 1979; 119():341-6. PubMed ID: 495291
[No Abstract] [Full Text] [Related]
44. α-Glucosidase inhibitory effect of resveratrol and piceatannol.
Zhang AJ; Rimando AM; Mizuno CS; Mathews ST
J Nutr Biochem; 2017 Sep; 47():86-93. PubMed ID: 28570943
[TBL] [Abstract][Full Text] [Related]
45. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man.
Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
Res Exp Med (Berl); 1979 Apr; 175(1):81-6. PubMed ID: 375342
[TBL] [Abstract][Full Text] [Related]
46. Manipulation of gut hormone response to food by soluble fiber and alpha-glucosidase inhibition.
Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson DL; Misiewicz JJ; Alberti KG
Am J Gastroenterol; 1988 Apr; 83(4):393-7. PubMed ID: 2831707
[TBL] [Abstract][Full Text] [Related]
47. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: dose-time-response relationships in man.
Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
Res Exp Med (Berl); 1979 Apr; 175(1):87-94. PubMed ID: 375343
[TBL] [Abstract][Full Text] [Related]
48. Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor.
Walton RJ; Sherif IT; Noy GA; Alberti KG
Br Med J; 1979 Jan; 1(6158):220-1. PubMed ID: 369651
[TBL] [Abstract][Full Text] [Related]
49. Influence of acarbose on blood glucose and breath hydrogen after carbohydrate load with sucrose or starch.
Koytchev R; Richter W; Erkent U; Kirkov V; Dimitrova V; Nern A; Kunter U
Arzneimittelforschung; 2009; 59(11):557-63. PubMed ID: 20066964
[TBL] [Abstract][Full Text] [Related]
50. L-arabinose selectively inhibits intestinal sucrase in an uncompetitive manner and suppresses glycemic response after sucrose ingestion in animals.
Seri K; Sanai K; Matsuo N; Kawakubo K; Xue C; Inoue S
Metabolism; 1996 Nov; 45(11):1368-74. PubMed ID: 8931641
[TBL] [Abstract][Full Text] [Related]
51. Influence of acarbose on hyperglycemia induced by various carbohydrates in rats and oral starch tolerance in monkeys.
Ho RS; Aranda CG
Arch Int Pharmacodyn Ther; 1983 Jan; 261(1):147-56. PubMed ID: 6847313
[TBL] [Abstract][Full Text] [Related]
52. Effect of a glucosidase inhibitor on the metabolic response of diabetic rats to a high carbohydrate diet, consisting of starch and sucrose, or glucose.
Gray RS; Olefsky JM
Metabolism; 1982 Jan; 31(1):88-92. PubMed ID: 7043164
[TBL] [Abstract][Full Text] [Related]
53. Effects of acarbose on starch hydrolysis. Study in healthy subjects, ileostomy patients, and in vitro.
Hiele M; Ghoos Y; Rutgeerts P; Vantrappen G
Dig Dis Sci; 1992 Jul; 37(7):1057-64. PubMed ID: 1618053
[TBL] [Abstract][Full Text] [Related]
54. Effect of acarbose (BAY-g-5421) on expression of noninsulin-dependent diabetes mellitus in sucrose-fed SHR/N-corpulent rats.
Carswell N; Michaelis OE; Prather ES
J Nutr; 1989 Mar; 119(3):388-94. PubMed ID: 2646401
[TBL] [Abstract][Full Text] [Related]
55. Postprandial glycemic control, hormonal effects and carbohydrate malabsorption during long-term administration of the alpha-glucosidase inhibitor miglitol.
Lembcke B; Diederich M; Fölsch UR; Creutzfeldt W
Digestion; 1990; 47(1):47-55. PubMed ID: 2292349
[TBL] [Abstract][Full Text] [Related]
56. Effect of sucrose and Acarbose feeding on the development of streptozotocin-induced diabetes in the rat.
Goda T; Yamada K; Sugiyama M; Moriuchi S; Hosoya N
J Nutr Sci Vitaminol (Tokyo); 1982 Feb; 28(1):41-56. PubMed ID: 6212654
[TBL] [Abstract][Full Text] [Related]
57. Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months.
Gérard J; Luyckx AS; Lefebvre PJ
Diabetologia; 1981 Nov; 21(5):446-51. PubMed ID: 7028558
[TBL] [Abstract][Full Text] [Related]
58. Lysosomal glycogen storage induced by Acarbose, a 1,4-alpha-glucosidase inhibitor.
Geddes R; Taylor JA
Biochem J; 1985 Jun; 228(2):319-24. PubMed ID: 3893420
[TBL] [Abstract][Full Text] [Related]
59. The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism?
Joubert PH; Venter HL; Foukaridis GN
Br J Clin Pharmacol; 1990 Sep; 30(3):391-6. PubMed ID: 2223417
[TBL] [Abstract][Full Text] [Related]
60. Effect of alpha-amylase and alpha-glucosidase inhibitors on caries incidence and plaque accumulation in rats.
Mörmann JE; Schmid R; Mühlemann HR
Caries Res; 1983; 17(4):353-6. PubMed ID: 6191863
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]